Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Google
Web www.equitybulls.com
Stock Report

| More

Lupin and Mylan receive European marketing authorization for Nepexto®, Biosimilar Etanercept

Posted On: 2020-06-04 17:43:23


Lupin Limited (Lupin) and Mylan N.V. (NASDAQ: MYL) today announced that the European Commission (EC) has granted marketing authorization for Nepexto®, a biosimilar to Enbrel® (etanercept), for all indications of the reference product including rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, axial spondyloarthritis (including ankylosing spondylitis and non-radiographic axial spondyloarthritis), plaque psoriasis and paediatric plaque psoriasis.

The regulatory approval follows the adoption of a positive opinion by the Committee for Medicinal Products for Human Use (CHMP) in March this year, which was based on a biosimilarity assessment including preclinical and clinical studies demonstrating bioequivalence to Enbrel. In addition, a phase 3 clinical study in patients with moderate-to-severe active rheumatoid arthritis confirmed equivalence of Nepexto to Enbrel in terms of efficacy, safety and immunogenicity.

The centralized marketing authorization applies to all member countries of the European Union.

Vinita Gupta, CEO, Lupin Limited said, "We are truly delighted with this approval. Nepexto is our first biosimilar to receive regulatory approval in Europe. With this important milestone, we bring an affordable biosimilar to the European market through our partner Mylan. Biosimilars like Nepexto will play a critical role in expanding access to patients in Europe, providing an effective treatment for multiple therapies including rheumatoid arthritis."

Mylan President, Rajiv Malik commented, "The approval of Nepexto, our biosimilar etanercept, is a positive step forward as we work to broaden our biosimilars franchise offerings and do our part to increase access to biologic treatments for patients in many European countries. This milestone reflects a strong scientific program behind Nepexto and commitment by our teams and our partner, Lupin, to bring the product to market as soon as possible. We look forward to launching Nepexto in the second half of this year."

Enbrel had sales of approximately $9.6 billion globally for the 12 months ending December 2019, according to IQVIA.

In June 2018, Lupin and Mylan announced a collaboration to commercialize a biosimilar to etanercept in several global markets.

Shares of LUPIN LTD. was last trading in BSE at Rs.907.7 as compared to the previous close of Rs. 867.05. The total number of shares traded during the day was 205191 in over 6746 trades.

The stock hit an intraday high of Rs. 912.75 and intraday low of 872.7. The net turnover during the day was Rs. 183935804.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com





Other Headlines:

ICICI Prudential Life Insurance Company Ltd board to approve 1st quarter FY21 results on July 21, 2020

Sharika Enterprises Ltd bags order from BHEL

Swelect Energy Systems Limited board recommends final dividend of Rs. 0.75

SpiceJet facilitates insurance of passengers for COVID-19 hospitalisation starting at Rs. 443/-

Shoppers Stop Limited opens new store at Phoenix Palassio - Lucknow

PI Industries Ltd closes QIP, fixes price as Rs. 1470

YES Bank has sold 2.66% stake in CG Power & Industrial Solutions Limited

NMDC's excellent performance at Bailadila Projects, Chhattisgarh, during lockdown

The Phoenix Mills Ltd. opens doors of its grand palatial shopping mall, Phoenix Palassio, in Lucknow

Swelect Energy Systems Ltd Q4 consolidated loss at Rs. 14.87 crore

Automotive Stampings and Assemblies Ltd reports loss in Q4 FY2020

SKY Industries Ltd posts loss of Rs. 0.63 crore in Q4 FY2020

SKY Industries Ltd board recommends final dividend of Rs. 0.50 for FY20

IndiGo repatriated 39 Indian nationals from Columbia, in coordination with Qatar Airways

Kokuyo Camlin Ltd Q4 FY20 loss at Rs. 0.34 crore

Muthoot Finance launches Loan@Home service

Mphasis named one of the UK's Top 50 fastest-growing Indian companies

NCC receives 5 new orders totalin Rs. 1396 crore in June 2020

Nestlé India reaches out to Youth-launches 1000 'Nesternship' opportunities for young professionals

Bharat Forge launches Health Risk Monitoring System (HRMS) - An AI platform enabling Safe return to Workplace

Heritage Foods Ltd board to consider Q1FY21 results on July 29, 2020

Intellect Digital Core (IDC) ranked world #1 by IBS Intelligence Annual Sales League Table 2020

Ambuja Cements Ltd board to consider 2nd quarter results on July 24, 2020

RBL Bank revamps 'RBL MyCard' credit card app

Thomas Cook India sees opportunity in demand for mini-breaks Introduces City Escapes

TCS Launches Quartz™ Smart Solution to Help Financial Institutions Offer Cryptocurrency Trading

Tactical Air Support selects Ramco Aviation Suite

Karur Vysya Bank and Bajaj Allianz Life Insurance announce strategic partnership

Tractor market to report strong growth in Q2 FY21 - Pritika Auto Industries Ltd

LTI Launches Canvas, a Modern Software Engineering Platform for Remote & Hybrid Workforce of Future

ITC facilitates creation of livelihood opportunities in the rural sector during the pandemic

ABB launches anti-bacterial switches and sockets to keep surroundings safe

Steel Strips Wheels Ltd receives $140K alloy wheels order from EU market

Nucleus FinnOne Neo recognized as the #1 Market Leader in Lending by IBS Intelligence

Lupin Pharmaceuticals, Inc. Issues Voluntarily Nationwide Recall of Metformin Hydrochloride Extended-Release Tablets, 500mg and 1000mg due to the detection of NDMA impurity

ICRA reaffirms long term rating of Puravankara Ltd

YES Bank Ltd board approves fund raising through FPO

GMR Infrastructure Ltd. announces the Completion of Strategic Partnership transaction with Groupe ADP for Airports Business

Infosys Ltd board to announce Q1FY21 results on July 15, 2020

Shree Renuka Sugars Ltd Q4 consolidated loss at Rs. 146 crore

ZIM announces submission of marketing authorization application for Rizatriptan orally dissolving film in Europe

KG Petrochem Ltd Q4 FY20 net profit jumps to Rs. 10.64 crore

Airtel launches NEW Prepaid Packs with Premium Content from ZEE5

Birlasoft partners with Innoveo to Fast-track the Journey to Digital Excellence

PPAP Automotive Limited receives award from Toyota Kirloskar Motor Pvt Ltd

Indian Acrylics Ltd Q4 FY20 PAT at Rs. 3.45 crore

India Infrastructure Trust board Declares total distribution of Rs. 4.4497

Best Agrolife Ltd Board approves final dividend of Rs. 0.10 for FY2020

A Infrastructure Ltd Board approves Dividend of Rs. 0.10 for FY20

Unichem Laboratories Limited receives ANDA approval for its Cyclobenzaprine Hydrochloride Tablets







Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2019